当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析

艾德生物

(300685)

  

流通市值:90.74亿  总市值:91.19亿
流通股本:3.90亿   总股本:3.92亿

艾德生物(300685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.63亿元,每股收益0.67元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益195892.21万元,未分配利润132649.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产224617.55万元,负债28725.34万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入865,632,981.04579,344,557.65272,090,793.911,108,948,700.11
营业总成本560,748,986.69358,787,743.26171,878,070.83793,982,033.11
其他经营收益
营业利润306,392,696.26222,738,181.68102,082,811.41292,977,984.44
利润总额300,817,448.37219,509,851.42101,793,500.12289,880,662.35
净利润262,505,939.1189,037,382.9690,471,778.52254,863,444.95
每股收益
其他综合收益106,770.0256,175.38--204,431.24
综合收益总额262,612,709.12189,093,558.3490,471,778.52254,659,013.71
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,995,678,659.231,920,009,529.971,891,421,886.641,788,399,896.77
非流动资产:
非流动资产合计250,496,885.42273,813,226.65272,090,942.66276,401,814.29
资产总计2,246,175,544.652,193,822,756.622,163,512,829.32,064,801,711.06
流动负债:
流动负债合计182,725,828.21225,025,173.42219,200,547.05194,822,578.72
非流动负债:
非流动负债合计104,527,586.0283,134,401.2725,465,308.7126,714,374.48
负债合计287,253,414.23308,159,574.69244,665,855.76221,536,953.2
所有者权益(或股东权益):
归属于母公司股东权益合计1,958,922,130.421,885,663,181.931,918,846,973.541,843,264,757.86
股东权益合计1,958,922,130.421,885,663,181.931,918,846,973.541,843,264,757.86
负债和股东权益合计2,246,175,544.652,193,822,756.622,163,512,829.32,064,801,711.06
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计916,140,935.3577,134,919.71290,859,140.411,171,890,950.61
经营活动现金流出小计640,754,341.83406,551,636.56187,604,287.57830,045,352.53
经营活动产生的现金流量净额275,386,593.47170,583,283.15103,254,852.84341,845,598.08
投资活动产生的现金流量:
投资活动现金流入小计268,871,410.51203,395,060.45-594,769,964.09
投资活动现金流出小计393,551,988.29234,630,370.7114,710,740.54668,069,311.36
投资活动产生的现金流量净额-124,680,577.78-31,235,310.25-114,710,740.54-73,299,347.27
筹资活动产生的现金流量:
筹资活动现金流入小计90,153,559.3665,129,357.98-249,405
筹资活动现金流出小计199,158,713.7172,727,465.5117,678,780.49159,889,765.02
筹资活动产生的现金流量净额-109,005,154.34-107,598,107.53-17,678,780.49-159,640,360.02
汇率变动对现金及现金等价物的影响3,602,104.049,345,925.352,606,466.465,478,078.36
现金及现金等价物净增加额45,302,965.3941,095,790.72-26,528,201.73114,383,969.15
期末现金及现金等价物余额360,764,801.21356,557,626.54288,933,634.09315,461,835.82
补充资料:
现金及现金等价物的净增加额-41,095,790.72-114,383,969.15
最新报告期:2025-11-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
光大证券王明瑞,黎一江0.870.971.092025-11-02
兴业证券东楠,孙媛媛,黄翰漾0.931.111.282025-10-28
中金公司俞波,张琎,陈诗雨0.831.00--2025-10-27
中信建投贺菊颖0.840.991.172025-10-16
国信证券张超0.810.981.152025-08-12
TOP↑